Allergy

CHOP's Food Allergy Bravery Clinic Helps Kids with Food Allergies Overcome Anxiety

Retrieved on: 
Wednesday, September 28, 2022

PHILADELPHIA, Sept. 28, 2022 /PRNewswire/ -- From an early age, children with life-threatening food allergies are taught to proceed with caution: check labels, ask about ingredients, don't eat something at a friend's house if you don't know what is in it. In some cases, however, necessary caution evolves into unnecessary avoidance – not only of foods but also of social situations where food might be served. This sort of disordered eating and avoidance is driven by anxiety, which if left unaddressed can significantly derail a child's quality of life and social development.

Key Points: 
  • The Food Allergy Bravery (FAB) program at CHOP provides cognitive behavioral therapy (CBT) in five to eight sessions to children who have severe anxiety related to their food allergies.
  • "This study shows that our Food Allergy Bravery program is a successful treatment for helping children with food allergy anxiety overcome their fears and improve their day-to-day life."
  • The FAB Clinic was launched in 2018 as a collaborative project to address food allergy anxiety.
  • Today, all patients seen with food allergies at CHOP are screened for anxiety and referred to the FAB Clinic as needed.

ModMed® Reveals Latest Digital Tools Aimed at Modernizing the Ophthalmology Patient Experience

Retrieved on: 
Wednesday, September 28, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220928005920/en/
    ModMed Reveals Latest Digital Tools Aimed at Modernizing the Ophthalmology Patient Experience (Graphic: Business Wire)
    In fact, 74% of patients place importance on online reviews when selecting a new doctor,* yet many physicians and providers do not have time to respond to reviews that could help protect their reputation.
  • AMP which stands for Advertise, Market, Promote is aimed at helping eye care professionals manage their online brand and reputation.
  • The full ModMed AMP solution also includes digital marketing, website design & management and e-commerce that work together with reputation management to enhance the digital footprint for practices.
  • ModMeds patient engagement tools connect seamlessly with ModMed Practice Management to help deliver a frictionless experience to patients.

Intrommune Expands and Strengthens Senior Leadership Team

Retrieved on: 
Wednesday, September 28, 2022

NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, today announced the appointment of Stuart Loesch as President and Dr. William Berger as Head of Clinical Development.

Key Points: 
  • Prior to joining Intrommune in August of 2021, Loesch gained a deep understanding of allergy immunotherapy as Vice President of Marketing, BD and Commercial Strategy at ALK.
  • He has also held several leadership roles within several societies and organizations, including past president of the American College of Allergy, Asthma & Immunology.
  • "I feel truly privileged to be part of a superb team here at Intrommune that is dedicated to developing safe and effective therapies for individuals suffering from food allergies.
  • Im excited to welcome Dr. Berger to Intrommune and look forward to working with him in this new role.

Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film for European and MENA Markets

Retrieved on: 
Wednesday, September 28, 2022

Pharmanovia CEO, James Burt, commented, Pharmanovia and Aquestive are aligned in our mission to find new and innovative ways to enhance and revitalize iconic medicines.

Key Points: 
  • Pharmanovia CEO, James Burt, commented, Pharmanovia and Aquestive are aligned in our mission to find new and innovative ways to enhance and revitalize iconic medicines.
  • Pursuant to the agreement, Aquestive Therapeutics will serve as the exclusive sole manufacturer and supplier for the product and Pharmanovia will be responsible for all regulatory and commercialization activities.
  • Aquestive will receive an undisclosed upfront payment and, if approved, milestone payments, and double-digit royalties on net sales of the diazepam buccal film in the licensed territories.
  • PharmFilm, Sympazan and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc.

2022 Allergy Capitals Report Highlights Most Challenging Cities for Fall Allergies

Retrieved on: 
Wednesday, September 28, 2022

While there is much overlap between the overall and fall rankings, some cities may be more impacted by ragweed pollen this time of year.

Key Points: 
  • While there is much overlap between the overall and fall rankings, some cities may be more impacted by ragweed pollen this time of year.
  • Ragweed is one of the main culprits for fall pollen allergies, and around 75% of people with pollen allergies are allergic to ragweed.
  • (PDF)
    For people with pollen allergies, there are over the counter and prescription medicine options available to prevent or treat fall allergy symptoms.
  • The Allergy Capitals ranking is an annual research and educational project of AAFA, designed to help patients recognize, prevent and safely treat allergy symptoms.

MomMed's FDA-Approved First-ever Fever Patch for Babies Now Available on Amazon

Retrieved on: 
Wednesday, September 28, 2022

NEW YORK, Sept. 28, 2022 /PRNewswire/ -- Leading online baby and maternity supply store, MomMed recently launched the first-ever fever patch for babies. Available on Amazon, the MomMed Fever Patch provides drug-free and anti-allergy instant cooling and pain relief for babies. This product is the first of its kind on the market aimed specifically at babies and helps to physically cool them down without harming their sensitive skin.

Key Points: 
  • First of its kind in the U.S. market, this fever patch is created specifically for babies.
  • NEW YORK, Sept. 28, 2022 /PRNewswire/ --Leading online baby and maternity supply store, MomMed recently launched the first-ever fever patch for babies.Available on Amazon , the MomMed Fever Patch provides drug-free and anti-allergy instant cooling and pain relief for babies.
  • Furthermore, the patch is drug-free, making it a safe choice to use in combination with other medications for babies.
  • Compared with other cooling solutions and fever patches, the MomMed Fever Patch uses different formulas for different ages to provide a more effective and safer product.

AcuCort reports positive results from the company's questionnaire study about allergy treatments

Retrieved on: 
Wednesday, September 28, 2022

LUND, Sweden, Sept. 28, 2022 /PRNewswire/ --AcuCort AB (publ) (Spotlight Stock Market: ACUC) reports today positive results from the company's questionnaire study on how allergy patients value their treatment.

Key Points: 
  • LUND, Sweden, Sept. 28, 2022 /PRNewswire/ --AcuCort AB (publ) (Spotlight Stock Market: ACUC) reports today positive results from the company's questionnaire study on how allergy patients value their treatment.
  • The questionnaire study includes a total of 426 patients who have answered questions about their allergy and how they value the available treatment options.
  • The results from the now completed questionnaire study are an important component of AcuCort's pricing and reimbursement application for ISICORT to the Swedish pricing and reimbursement agency, TLV.
  • "We are very happy about the positive results from our questionnaire study on allergy treatment.

AcuCort reports positive results from the company's questionnaire study about allergy treatments

Retrieved on: 
Wednesday, September 28, 2022

LUND, Sweden, Sept. 28, 2022 /PRNewswire/ --AcuCort AB (publ) (Spotlight Stock Market: ACUC) reports today positive results from the company's questionnaire study on how allergy patients value their treatment.

Key Points: 
  • LUND, Sweden, Sept. 28, 2022 /PRNewswire/ --AcuCort AB (publ) (Spotlight Stock Market: ACUC) reports today positive results from the company's questionnaire study on how allergy patients value their treatment.
  • The questionnaire study includes a total of 426 patients who have answered questions about their allergy and how they value the available treatment options.
  • The results from the now completed questionnaire study are an important component of AcuCort's pricing and reimbursement application for ISICORT to the Swedish pricing and reimbursement agency, TLV.
  • "We are very happy about the positive results from our questionnaire study on allergy treatment.

19Labs announces GALE Augmented Reality: Transforming the Clinician Telemedicine Experience

Retrieved on: 
Tuesday, September 27, 2022

REDWOOD CITY, Calif., Sept. 27, 2022 /PRNewswire/ -- Until now, the telehealth industry has focused on the consumer experience of video calls with the clinician experience often being an afterthought. This creates challenges for telemedicine clinicians who must juggle video calls with electronic medical records, data from diagnostic devices and more, in real time, during live patient consultations. This necessitates costly additional clinician training, impedes rapport with the patients, and challenges acceptance into clinical workflows.

Key Points: 
  • REDWOOD CITY, Calif., Sept. 27, 2022 /PRNewswire/ -- Until now, the telehealth industry has focused on the consumer experience of video calls with the clinician experience often being an afterthought.
  • The new GALE InsightsAR solves these issues by creating a unified, seamless consult experience over standard Zoom Meetings.
  • All patient information, vital signs and medical records are directly overlayed over the Zoom Meeting using 19Labs' patented augmented reality technology.
  • 19Labs' solution combines telemedicine, EMR, diagnostic devices and Zoom Meetings into a seamless, simple, secure experience.

Kiwi Organic Mattress from My Green Mattress Wins Good Housekeeping's 2022 Parenting Award

Retrieved on: 
Tuesday, September 27, 2022

CHICAGO, Sept. 27, 2022 /PRNewswire/ -- Family owned-and-operated My Green Mattress is pleased to announce that their Kiwi Organic Mattress won Good Housekeeping's 2022 Parenting Award as a Fantastic First Mattress in the Superb Sleep Star category.

Key Points: 
  • CHICAGO, Sept. 27, 2022 /PRNewswire/ --Family owned-and-operated My Green Mattress is pleased to announce that their Kiwi Organic Mattress won Good Housekeeping's 2022 Parenting Award as a Fantastic First Mattress in the Superb Sleep Star category.
  • The Kiwi Mattress is GOTS and GOLS certified organic and free of harmful chemicals.
  • The eco-friendly mattress is made to order with a pocketed coil innerspring and sustainable materials including organic Dunlop latex, organic wool and organic cotton for contouring support and breathability.
  • The Kiwi Organic Mattress is the most affordable in the organic mattress industry.